Hydroxychloroquine, and old acquaintance that gained strength in the pandemic.

Abstract

As of December 2019, the COVID-19 epidemic represented one of the major therapeutic challenges faced to date, even more so when the use of medicines that were already known and perhaps forgotten by most of the medical community, but which were part of the rheumatologist's daily routine, was proposed. Specifically, we have witnessed the evolution on the evidence regarding the usefulness or not of an old acquaintance, Hydroxychloroquine.

Keywords

• covid-19
• rheumatology
• hydroxychloroquine
• medical community
• therapeutic challenges
• podcast
• pandemic